© 2026 BioMarin. All rights reserved. Developed and funded by BioMarin.
Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition we hope to address.
Learn More about our pipline ⌃You are about to leave the BioMarin.eu website and will be redirected to BioMarin’s global website owned and operated by our headquarters, BioMarin Pharmaceutical Inc., located in the United States. Please note that the BioMarin.com (US) website uses cookies to help personalise content, measure advertisements, and provide a safer user experience. By clicking “Proceed Anyway”, you will be automatically redirected to the BioMarin.com (US) website and agree to the use of cookies and similar technologies as described in the Privacy Policy and can manage your detailed cookie choices by clicking on Cookie Preferences. Otherwise, click “Return to BioMarin.eu”.
You are about to leave the BioMarin.eu website. BioMarin makes no warranties or representations of any kind as to the accuracy, completeness, reliability or usefulness of any information contained in third party sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information. Inclusion of any third party link does not imply an endorsement or recommendation by BioMarin.
You are about to leave the BioMarin.eu website and will be redirected to BioMarin’s global website owned and operated by our headquarters, BioMarin Pharmaceutical Inc., located in the United States. Please note that the BioMarin.com (US) website uses cookies to help personalise content, measure advertisements, and provide a safer user experience. By clicking “Proceed Anyway”, you will be automatically redirected to the BioMarin.com (US) website and agree to the use of cookies and similar technologies as described in the Privacy Policy and can manage your detailed cookie choices by clicking on Cookie Preferences. Otherwise, click “Return to BioMarin.eu”.